@MilesCcc @ELRIG_SCIENCE Find out more about the event here: https://t.co/OHhxDJN5aN ...

Join our Chief Scientific Officer, @MilesCcc, at @ELRIG_SCIENCE Drug Discovery 2025: Festival of Life Science in Liverpool, on 21 October at 14:00 BST, where he will explore how @IsomorphicLabs integrates its advanced structure prediction models with bespoke machine learning approaches to binding affinity and ADMET optimisation – unlocking chemical spaces traditional methods struggle to reach. ...

@caseymross @STAT Find out more about the event here: https://t.co/1QH9MzAsko ...

Our Chief Medical Officer, Dr. Ben Wolf, will be joining @caseymross from 11:20 - 11:45am EDT on 16 October at the @STAT Summit to talk about why our mission to solve all disease inspired him to bring his 20 years of drug development experience to Isomorphic Labs. https://t.co/yT9DIHUeEd ...

Join @maxjaderberg , our Chief AI Officer, and @MilesCcc, our Chief Scientific Officer, in a virtual fireside with @AndrewE_Dunn at the 2025 Endpoints AI Day on 14 October, from 11:00-11:40am EDT.Together, Max and Miles will delve into how AI and drug discovery come together in their work at Isomorphic Labs, and how our drug design engine enables us to operate across many different therapeutic areas and drug modalities. ...

@maxjaderberg @MilesCcc @AndrewE_Dunn Sign up now: https://t.co/m2Z329hdl8 ...

Join @maxjaderberg, our Chief AI Officer, and @MilesCcc, our Chief Scientific Officer, in a virtual fireside with @AndrewE_Dunn at the 2026 Endpoints AI Day on 14 October, from 11:00-11:40am EDT.Together, Max and Miles will delve into how AI and drug discovery come together in their work at Isomorphic Labs, and how our drug design engine enables us to operate across many different therapeutic areas and drug modalities. ...

@SergeiIakhnin @BioTechX_ Find out more: https://t.co/4rOADZjcHx ...

In less than a week, our CTO @SergeiIakhnin will open @BioTechX_ EU with his keynote: "AI Models from Atoms to Humans: the Era of Rational In Silico Drug Design."Join him in Basel on October 6th, at 9am CEST to explore how advanced AI is already reinventing drug discovery, and his vision for a future where it accelerates breakthroughs that move us closer to solving all disease. ...

Last week, our Chief Scientific Officer @MilesCcc participated in @BioCentury Grand Rounds Europe in Cambridge, UK. During his "Small Compounds, Big Potential" panel, Miles discussed how technology is accelerating and reducing the cost of molecule creation, and the collaborative efforts of academia, start-ups, and industry in advancing drug development. ...